Dr. Saad Saad is a well-know pediatric surgeon. He has held his medical degree for 47 years since earning his degree from the prestigious Cairo University in Egypt. The man learned much about the field in that school where he was able to graduate with honors earning scores that propelled him to be the second highest in this class.
Saad decided to complete his internship in England before deciding to immigrate to the United States of America. England was very different from his home country but it was an exciting two years. He learned a lot about the culture and how enriching it could be to be around other people, which started to make the US a lot more enticing since it is known to some as a melting pot of cultures.
He finished up additional studies when he made it to America to become a fully USA Board Certified Pediatric Surgeon. It is no surprise that Dr. Saad has gotten far in life since education has always been a major aspect of his life. He sat down for an interview and talked about his life.
One thing he mentioned was that he comes from a family of eight children. Every child has focused on education one way or another. He mentioned that three of the siblings are surgeons and two are doctors. Two of the other siblings are engineers and one focused on teaching.
Dr. Saad said he teached his children about the importance of education, which may have encouraged two of them to become surgeons like their father. Another child became a lawyer and the other is an nurse. Perhaps this is the reason he tries to tell others who are interested in the field to seek education whenever possible.
Dr. Saad also mentioned how reaching his dreams of becoming a surgeon has given him the gift of a giving heart. He mentioned how he’s provided help to those who need the most by volunteering for Medical Missions in places like Jerusalem.
Saad cracked a smile when he pointed out that his dream of becoming a surgeon was birthed out his desire for an good air conditioned room. When he was a kid, he remembers suffering through really hot temperatures that exceeded 110 degrees. He wanted a job that would take him away from the heat, which is how he came to surgery.
Stock options have been associated with a lot of problems. They have been associated with overhang and being an accounting burden to the accountants. As a result, there has been a push to change this situation by offering alternative compensation methods that will fill in the gaps that are created by the stock options.
According to compensation lawyer, Jeremy Goldstein of Jeremy L. Goldstein & Associates, there is an option called “Knockout Barrier” option. This is an option that solves the problems associated with the stock options. It has a time limit over which it is valid. In case the prices fall, the options may be deemed to have expired. It is still clear that the employees risk losing their options in case the process falls. However, the business will benefit from reducing the accounting burden, and the risk of stock overhang will be eliminated.
Why does the accounting burden reduce? When the option is time-bound, let say an hour, an account will not have a hard time recording the transitions involved. Knockout Options, unlike the stock options, enable the accountants to prepare a clean annual report that is easy to read and comprehend. To the workers, Knockout options offer attractive benefits.
Knockout barrier options may not have all the answers to workers compensation issues, but at least they eliminate all the problems associated with all other forms of compensation. So far it is the best method and is recommended by Jeremy Goldstein, a prominent lawyer in New York.
The above is not the only incentive methods that can be applied in a business environment. There are other methods, but all in all, the applicability of the method depend on the goals of accompany. A method that works for one company may not work for another.
Jeremy advises companies to choose the methods that best fit their business goals. In his many years of experience, he has seen some companies get into trouble financially for making decisions which do not match with their mode of operations.
Another method that is commonly used is the “Earnings per Share.” This is a payment method that is based on the performance of an employee. EPS is a method that determines the stock prices of a company. The stock price determines if people will invest in a company or not. So, how a company implements the EPS will determine the growth of the business.
About Jeremy Goldstein
Jeremy Goldstein is a compensation lawyer who has worked for big corporations in the country. Jeremy Goldstein has a huge reputation and remains one of the best performing law firms in the country. He has worked with the likes of AT&T and Verizon. Jeremy Goldstein has a law firm called Jeremy L. Goldstein & Associates. It is based in New York. Learn more: https://www.quora.com/profile/Jeremy-Goldstein-20
Perry Mandera is the owner of Custom Companies, Inc., a logistics company that aims to deliver freight and cargoes on time. The company was established in 1986, and since then, more businesses have been tapping their services because of its positive reputation. Perry Mandera managed to grow his business through the years of innovation and development. The once small logistics company is now earning more than $200 million every year, thanks for the increasing number of customers and clients that trust the Custom Companies, Inc. for their freight and cargo transport needs. For the past 30 years of operation, Perry Mandera teamed up with bright minded programmers to create some software that would assist him in managing his business, and at the same time, provide an excellent service to his clients and customers. The software that has been integrated into his company system is the Cheetah Dispatch, the Warehouse Management System, and the Dock Management System. Each software is given a task that enables Perry Mandera to monitor the business and all of its departments remotely. So far, the integration of technology to the operation of Custom Companies, Inc. is proven to be effective.
With Cheetah Dispatch, the freight and cargo transported through Custom Companies, Inc. can be tracked with the latest GPS technology. The item can be traced down as it goes out of its origin, as it is being transported, and as it reaches its destination (https://www.behance.net/manderaperry). The software gives the senders of the items a peace of mind that their freight and cargoes are in good hands, and it will be delivered to the right address.
Another software being used by Custom Companies, Inc. is the Warehouse Management System, which allows those who have used the services from Perry Mandera’s company to trace down all of the warehouses where the item will be transported (Strikingly). It will enable the customers and clients to track the location of the object, giving them the confidence that it will not be lost.
Finally, the Dock Management System is a software that enables the customers and clients of Custom Companies, Inc. to check each seaport and airport for their items.
Those of us who have enjoyed Organo Gold were already aware of the immense health benefits it offers, but now we have some independent scientific research to back us up. Two new studies published in the Annals of Internal Medicine show a link between moderate coffee drinkers and a reduced risk from diseases such as heart disease and stroke.
The studies examined 185,000 Americans and found they saw increased health benefits regardless of whether they drank caffeinated or decaffeinated coffee. It didn’t matter whether the Americans had Latino, Japanese, or African heritage either; they all indicated a lesser risk for heart disease, cancer, stroke, diabetes and kidney disease.
“Seeing a similar pattern across different populations gives stronger biological backing to the argument that coffee is good for you whether you are white, African-American, Latino or Asian,” lead author and UCLA Associate Professor of Meicine Veronica W. Setiawan said in a prepared statement.
The American Sample group regularly reported their coffee drinking habits to the researchers over a period of five years. Setiawan and her team were pleased with the results. “We cannot say drinking coffee will prolong your life, but we see an association,” she said.
A similar European study also surveyed 520,000 people across ten countries and found similar results. The researchers realized their study wasn’t without limitations, and they separated other factors such as smokers from the study as well. To say this study bodes well for those who enjoy their morning cup of Joe is an understatement.
Organo Gold has always been dedicated to delivering only the best cup of coffee to everyone. Moreover, each cup of their coffee has a host of health benefits without sacrificing on the original taste that everyone loves so well. We at Organo Gold look at this study and realize these researchers are simply waking up to something we have known all along!
Amicus Therapeutics is a biotechnological company recognized globally for their dedication towards the treatment of orphan diseases. The company has been at the forefront of research and treatment of a range of devastating rare diseases.
Amicus Therapeutics was founded in February 2002 and is based in Cranbury, New Jersey. The company is headed by John Crowley, who is the CEO and Chairman of the board. Other key figures include Bradley Campbell, who is the Chief Operations Officer, and William Baird, who is the Chief Finance Officer. Amicus Therapeutics is a publicly traded company under the brand NASDAQ. The company has been on the stock exchange since 2007 after a planned IPO.
Amicus mainly focuses on rare and orphan diseases (http://www.phillypurge.com/2017/08/02/amicus-therapeutics-the-fight-against-the-rare-diseases/). The Chaperone-Advanced Replacement Therapy, otherwise referred to as CHART is the main basis of the company’s product development. Amicus has put an emphasis on enzyme replacement therapies (ERTs). The company’s efforts have earned them accolades. In 2014, Amicus was recognized as the company with the broadest portfolio in terms of small molecule pharmacological chaperones in the entire pharmaceutical industry.
Although they had no marketed products by February 2014, some of the most notable developments from Amicus Therapeutics include migalastat, otherwise known as Galafold. Galafold is a pharmacological chaperone treatment which is aimed at stabilizing endogenous mutant alpha-galactosidase for the treatment of Fabry disease.
Amicus Therapeutics has no manufacturing capabilities and therefore relies on contract manufacturing (WeeklyOpinion). Additionally, the company collaborates with other like-minded firms to come up with treatments for complex diseases. One of its most notable collaborations was with GlaxoSmithKline and JCR Pharmaceutical. The collaboration which lasted from 2010 to 2013 was aimed at investigating co-formulation with recombinant alpha-galactosidase.
It is worth noting that in 2008, the company expanded its activities from its single location in New Jersey to a second research facility in San Diego. Additionally, Amicus got a big financial boost, when they received a US$500,000 grant in 2010 from the Michael J. Fox Foundation. The grant was aimed at supporting studies conducted by Amicus in collaboration with the David Geffen School of Medicine.
In 2013, Amicus went a step further and acquired CallidusBiopharma, which was one of their competitors. The acquisition granted Amicus Therapeutics intellectual and material property for the treatment of Pompe disease.
Alexandre Gama is a Brazilian advertising entrepreneur. He is a very skilled businessman with creativity and professionalism in both Advertising and Publicity. There are about 20 largest advertising agencies in Brazil, and among them is Neogama, an agency that Gama founded in 1999 and is currently its CEO and CCO.
Alexandre Gama graduated from Fundação Armando Alvares Penteado (FAAP), with a degree in Publicity and Advertising. The Brazil communication industry felt his presence when he started representing it after he joined ABAP. Since then, Gama has worked with other companies like BBH, DM9, among others. It is when he was the CEO of BBH that Gama became the first Brazilian to be on the leader board of global communication agencies. In 2002, Alexandre associated the two companies; Neogama and BBM, the London branch. In 2016, however, after 14 years of activity, Gama cut off the BBM network and renamed it Neogama. He showed a lot of dedication to the success of the company and put both his heart and hard work into it.
His career has had waves of successes. He has received an astounding number of awards over the years, among which are the most prestigious in Brazil. He was elected Officer of Agency of the Year, in 2006; and he received a prize for being the entrepreneur of the year, as well as a successful manager of the communications industry in 2007. Between 2009 and 2017, he has received several other awards like the prestigious Golden Lion award, which he has been accorded more than once.
If it were not for leaders like Matthew Autterson, America would not be recovering from the past damage that Pres. Obama has cost. FAB holds that Matthew Autterson is quite an asset to have in the Greater Denver Area and that he is its greatest weapon in the fight for reforming biotechnology education. What is interesting to note is that both Matthew Autterson and his wife have been working very hard in there six months in office and have, so far, kept several of the promises they made to make it in this year alone. The level of progress is astounding and only shows potential.
It appears, after all, that Matthew Autterson and his team were people of their word and intended to do just what they said when they ran for leadership roles. This is exceptionally rare to see among any biotech leader, but let it serve as a lesson to all who are running for rank: Do exactly what you promised to do, and do not lie as a way to power, for you will be found out. Instead, go the honest route and work hard, and your reputation will more than speak for itself in the long run – as it has done so for CNS Biosciences President Matthew Autterson and his team. Pres. Matthew Autterson and his crew are not alone as they also hold other top candidates in the offices surrounding them, men and women of solid conservative values who only care about the good of this country and not merely their wallets.
This makes all the difference, so keep it in mind: With such leaders behind the science arena, there is no doubt that America can change for the better. Let us keep hoping and praying. Let us support as needed and make the change. God bless America. Peace and justice to all Americans. The educational biotech arena has an entire future ahead of it, and this is only the beginning: Will you lead the change?
Matthew Autterson is a top reformer and biotech specialist. As Board Member under FAB, he has more than his share of challenges but faces them willingly. He knows, after all, what he signed up for. He has also promised to do more this year that has ever been done recently to reform the biosystem sector in Colorado and has been no less ahead in the fight than others.
The Mexican media industry hosts some of the most influential media houses in the world. Many companies have come up, and content in areas of news and entertainment has also improved. Gone are the days when the citizens were treated to a single media outlet owned by the government. With contributions of top personalities like Alfonso de Angoitia Noriega, the industry is headed in the right direction. Here are a few of the top companies in the sector.
Grupo Salinas is another top media company in Mexico with several local television channels. They include Azteca 7 and Azteca Trece. The Mexico City-based firm owns a few pay television channels that include adn40 and a+.
Grupo ACIR has graced the Mexican Media scenes since the year 1960. Its main focus has always been in the radio operations. It owns several radio stations with a few being online. These stations include Azul, City, Radio Disney, Amor, and radio Felicidad.
About Alfonso de Angoitia Noriega
Alfonso de Angoitia Noriega started working for Grupo Televisa as the CFO. His impeccable performance led him to his current position of the senior VP of the firm. Alfonso de Angoitia Noriega also sits on the board of directors of the company.
Before joining Grupo Televisa, Alfonso Angoitia Noriega worked for the White & Case LLP. in New York. His other engagements include being a director of Bolsa Mexicana de Valores.
NuoDB gives you the power to make optimizations without having to worry about any disk limitations. It also lets you preserve reliable support for SQL database and user-based security models. NuoDB lets you operate in your environment of choice, such as on-premises, in containers, or in a hybrid cloud. Messages between NuoDB processes at also always automatically encrypted for extra security.
With NuoDB, you can maximize all o your resources across data centers within close- proximity and even minimize client and application latencies. Its in-memory caches will even automatically adjust sot that you an get optimal workload performance and ass or remove compute power.
NuoDB is capable of withstanding failure at every level without the risk of bringing down your application. You can also easily migrate application code that is already in pace using in-database processing in order to achieve better performance.
NuoDB is focused on delivering a cloud database that is not only more intelligent, but that can also easily adapt to the ever-changing environment. NuoDB combines elasticity, stability, and simplicity that cloud applications require and can keep up to the toughest and most rigorous demands of the modern day world. NuoDB gives you the power that you can rely on.
NouDB is a cloud technology that divides the elements of data into software objects known as atoms. This gives support to the elasticity of the cloud and at the same time ensure that data objects are properly stored and well maintained. Also, the technology of NouDB supports MVCC (Multi-Version Concurrency Control), which helps with the detection of data deadlocks and offer solutions to access conflicts. Additionally, the design of the NouDB’s cloud database is unique in that it can employ message-oriented and object-oriented elements. These elements can be distributed using computing methodologies and peer-to-peer communication format.
The developer and marketer of NouDB technology is NouDB Inc., which also act as the vendor of the technology. NouDB Inc. was founded in 2008 as NimbusDB. Later on, NouDB 1.0 software was released in 2013 and a new series is currently in the market, which is NouDB 2.0.3. The consumers of NouBD software like it because it is flexible and has a scalable database foundation. It helps users to keep up with the pace and demand of the growing business environment. Perhaps, it is one of the most cost-effective SQL databases that can help consumers expand their business activities. It is also easy to migrate most of the applications to the cloud while using NouDB technology.